3 completed, 1 unknown, 1 withdrawn. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Nonmalignant Neoplasm: new trials by email Literature Review of Nonmalignant Neoplasm trials Research Report on Nonmalignant Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer cyclosporine, mycophenolate mofetil, pentostatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 1 / Phase 2 | Withdrawn | University of Nebraska | 2008-09-01 | 2023-08-14 | |
| Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome nonmyeloablative allogeneic hematopoietic stem cell transplantation - Leukemia, Myelodysplastic Syndromes | Phase 2 | Completed | Asan Medical Center | 15 | 2008-04-01 | 2015-12-31 |
| Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure alemtuzumab, cyclosporine - Nonmalignant Neoplasm | Phase 2 | Unknown | Federico II University | 50 | 2006-06-01 | 2013-08-12 |
| RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS Rapamycin - Nonmalignant Neoplasm, Tuberous Sclerosis | Phase 2 | Completed | Dana-Farber Cancer Institute | 36 | 2005-12-20 | 2022-04-25 |
| Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer anti-thymocyte globulin, busulfan, carboplatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 2 / Phase 3 | Completed | Roswell Park Cancer Institute | 361 | 1998-10-19 | 2021-08-13 |
Neoplasms (5) · Anemia, Aplastic (4) · Leukemia (3) · Myelodysplastic Syndromes (3) · Anemia, Refractory (2) · Blast Crisis (2) · Congenital Abnormalities (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myeloid, Accelerated Phase (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myeloid, Chronic-Phase (2) · Leukemia, Myelomonocytic, Chronic (2) · Lymphoma (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2)
Anemia (4) · Bone Marrow Diseases (4) · Bone Marrow Failure Disorders (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms by Histologic Type (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Blood Coagulation Disorders (2) · Blood Platelet Disorders (2) · Bone Marrow Neoplasms (2) · Carcinogenesis (2) · Cell Transformation, Neoplastic (2) · Chronic Disease (2) · Disease Attributes (2) · Hematologic Neoplasms (2)
Cyclosporine (2) · Whole-Body Irradiation (2) · Alemtuzumab (1) · Antilymphocyte Serum (1) · Busulfan (1) · Carboplatin (1) · Cyclophosphamide (1) · Cyclosporins (1) · Cytogenetic Analysis (1) · Etoposide (1) · Flow Cytometry (1) · Immunoenzyme Techniques (1) · In Situ Hybridization, Fluorescence (1) · Melphalan (1) · Mycophenolic Acid (1)
Asan Medical Center (1) · Dana-Farber Cancer Institute (1) · Federico II University (1) · Roswell Park Cancer Institute (1) · University of Nebraska (1)
United States (2) · Italy (1) · South Korea (1)
Bruno Rotoli, MD (1) · Kyoo H. Lee, MD (1) · Philip L. McCarthy, MD (1) · Robert Bociek, MD (1) · Sandra Dabora, MD, PhD (1)
P30CA006516 (1), P30CA036727 (1), R01CA107164 (1)